TECVAYLI

Google image searchProduct monograph

Active ingredient

teclistamab, 153 MG/1.7 ML

DIN: 02539764

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: JANSSEN INC

Date: 20-OCT-2023

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01F — MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES (ATC, ATC/DDD)
• L01FX — Other monoclonal antibodies and antibody drug conjugates (ATC, ATC/DDD)
• L01FX24 — TECLISTAMAB (ATC/DDD)

External Links for Tecvayli

Search on Google

• Tecvayli side effects
• Tecvayli dosage
• teclistamab side effects
• teclistamab dosage

Janssen Inc

Go to Janssen website to see drug product details. Sometimes you can find tecvayli photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.